Point-of-care glucose testing involves measurement of blood glucose levels of the patient at the point of care or bedside. It does not include sending blood samples for analysis to the laboratory. It is commonly used in the management of diabetes. Products used for point-of-care glucose testing include strips, lancets and lancing devices, and meters.
The Japan point-of-care glucose testing market is expected to witness substantial growth in the coming years owing to the surge in awareness of diabetes among consumers, government-led initiatives, and enterprises committing to enhancing healthcare across the country.
Further, stringent regulatory requirements for approval of glucose meters and other point-of-care glucose testing devices restrains the growth of the market in Japan.
Technological advancements such as wireless connectivity for glucose testing which helped monitor and maintain a record of the glucose levels without human involvement, attract the customers who are aware of the importance of maintaining a record of the glucose levels, and prefer to do so from the comfort of their home. This increases the demand for such devices, in turn, fostering the growth of the Japan point-of-care glucose testing market.
The Japan point-of-care glucose testing market is segmented on the basis of product type, application, and end user. On the basis of product type, the market is classified into lancing devices & strips, and blood-glucose meter. The blood-glucose meter segment is further bifurcated into Lifescan one touch ultra & Lifescan one touch verio; Accuchek Aviva Plus & Accuchek; FreeStyle Lite & FreeStyle precision neo; Contour Next; and others. On the basis of application, the market is classified into type-1 diabetes, and type-2 diabetes. As per end user, it is segregated into hospitals & clinics, home care settings, and others.
Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Siemens Healthcare, Arkray Inc., Otsuka Pharmaceutical Co., FUJIFILM Holdings Corp., ETHICON, Inc., Novo Nordisk A/S and OLYMPUS CORPORATION are some of the major players in the Japan point-of-care glucose testing market. Further, five emerging companies in the market include Bionovate, ARKRAY USA Inc., Diatrics, Ciphergen Biosystems, and LifeScan. Companies in Japan are focusing on partnerships and collaborations to sustain the intense competition in the market.
New product developments, are thus, observed and expected in the Japan point-of-care glucose monitoring market, as the country adopts advanced technologies to manage healthcare facilities. The future of the Japan point-of-care glucose monitoring market is thus marked by integration of technology, stringent regulations, and patient-centric design, which play a pivotal role in shaping its growth in the coming years.
The Japan point-of-care glucose testing market is anticipated to witness growth during the forecast period owing to technological advancements and adoption of IoT or wireless technologies. A lot of people prefer home care settings to monitor their health. To cater the same, a lot of companies are coming up with wireless monitoring devices which enable the patient to monitor the health from home and similarly feed and maintain the data remotely in the laboratory. This also prevents the patients from visiting the laboratory. These is an increase in demand for such devices to monitor glucose levels in Japan as well. This, in turn, fosters the point-of-care glucose testing market growth in Japan.
The Japan point-of-care glucose testing market is expected to witness substantial growth in the coming years owing to the surge in awareness of diabetes among consumers, government-led initiatives, and enterprises committing to enhancing healthcare across the country.
Further, stringent regulatory requirements for approval of glucose meters and other point-of-care glucose testing devices restrains the growth of the market in Japan.
Technological advancements such as wireless connectivity for glucose testing which helped monitor and maintain a record of the glucose levels without human involvement, attract the customers who are aware of the importance of maintaining a record of the glucose levels, and prefer to do so from the comfort of their home. This increases the demand for such devices, in turn, fostering the growth of the Japan point-of-care glucose testing market.
The Japan point-of-care glucose testing market is segmented on the basis of product type, application, and end user. On the basis of product type, the market is classified into lancing devices & strips, and blood-glucose meter. The blood-glucose meter segment is further bifurcated into Lifescan one touch ultra & Lifescan one touch verio; Accuchek Aviva Plus & Accuchek; FreeStyle Lite & FreeStyle precision neo; Contour Next; and others. On the basis of application, the market is classified into type-1 diabetes, and type-2 diabetes. As per end user, it is segregated into hospitals & clinics, home care settings, and others.
Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, Siemens Healthcare, Arkray Inc., Otsuka Pharmaceutical Co., FUJIFILM Holdings Corp., ETHICON, Inc., Novo Nordisk A/S and OLYMPUS CORPORATION are some of the major players in the Japan point-of-care glucose testing market. Further, five emerging companies in the market include Bionovate, ARKRAY USA Inc., Diatrics, Ciphergen Biosystems, and LifeScan. Companies in Japan are focusing on partnerships and collaborations to sustain the intense competition in the market.
New product developments, are thus, observed and expected in the Japan point-of-care glucose monitoring market, as the country adopts advanced technologies to manage healthcare facilities. The future of the Japan point-of-care glucose monitoring market is thus marked by integration of technology, stringent regulations, and patient-centric design, which play a pivotal role in shaping its growth in the coming years.
The Japan point-of-care glucose testing market is anticipated to witness growth during the forecast period owing to technological advancements and adoption of IoT or wireless technologies. A lot of people prefer home care settings to monitor their health. To cater the same, a lot of companies are coming up with wireless monitoring devices which enable the patient to monitor the health from home and similarly feed and maintain the data remotely in the laboratory. This also prevents the patients from visiting the laboratory. These is an increase in demand for such devices to monitor glucose levels in Japan as well. This, in turn, fosters the point-of-care glucose testing market growth in Japan.
Key Benefits For Stakeholders
- Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
- Analyze the key strategies adopted by major market players in Japan point-of-care glucose testing market.
- Assess and rank the top factors that are expected to affect the growth of Japan point-of-care glucose testing market.
- Top Player positioning provides a clear understanding of the present position of market players.
- Identify key investment pockets for various offerings in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Product Benchmarking / Product specification and applications
- Upcoming/New Entrant by Regions
- New Product Development/ Product Matrix of Key Players
- Patient/epidemiology data at country, region, global level
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Product Type
- Lancing Devices and Strips
- Blood-Glucose Meter
- Type
- Lifescan OneTouch Ultra and Lifescan OneTouch Verio
- Accu-Chek Aviva Plus and Accuchek
- Freestyle Lite and Freestyle Precission Neo
- Contour Next
- Others
By Application
- Type-1 Diabetes
- Type-2 Diabetes
By End User
- Hospitals and Clinics
- Home Care Settings
- Others
- Key Market Players
- Abbott Laboratories
- Roche Diagnostics
- Sysmex Corporation
- Siemens Healthcare
- Arkray Inc.
- Otsuka Pharmaceutical Co.
- FUJIFILM Holdings Corp.
- ETHICON, Inc.
- Novo Nordisk A/S
- OLYMPUS CORPORATION
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
CHAPTER 5: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
CHAPTER 6: JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
CHAPTER 7: COMPETITIVE LANDSCAPE
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Companies Mentioned
- Abbott Laboratories
- Roche Diagnostics
- Sysmex Corporation
- Siemens Healthcare
- Arkray Inc.
- Otsuka Pharmaceutical Co.
- FUJIFILM Holdings Corp.
- ETHICON, Inc.
- Novo Nordisk A/S
- OLYMPUS CORPORATION
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
